Brain Response to Treatment for Pediatric PTSD

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT01806701
Collaborator
National Institute of Mental Health (NIMH) (NIH)
68
1
1
37
1.8

Study Details

Study Description

Brief Summary

This study will examine how brain activation changes as a result of behavioral treatment for posttraumatic stress disorder (PTSD) in adolescents. The investigators will conduct functional magnetic resonance imaging (fMRI) scans before and after the widely-used trauma-focused cognitive behavioral therapy to better understand how the brain recovers from illness. This study will provide much needed information about brain abnormalities in abused youth, and could lead to improvements in behavioral treatments for patients who do not respond to current treatments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Trauma-focused cognitive behavioral therapy
N/A

Detailed Description

This is a neuroimaging study of changes in brain function associated with trauma-focused cognitive behavioral therapy (TF-CBT)for abused youth suffering from PTSD. By scanning patients before and after treatment, the investigators will identify mediators (potential mechanisms) of recovery from PTSD.

Childhood maltreatment is unfortunately common, and can lead to significant problems in school, emotional difficulties, and physical ailments. Frequently, abused children develop symptoms of posttraumatic stress disorder (PTSD), such as re-experiencing aspects of the trauma, avoiding trauma-related situations, and suffering from chronic hyperarousal. PTSD can inflict significant stress-related damage on the brain at any age, but may be particularly damaging during developmental periods such as adolescence. Therefore, effective treatments for PTSD in youth are critical, and this depends in part on our ability to understand the neural abnormalities underlying pediatric PTSD, and the brain changes accompanying recovery from PTSD.

TF-CBT is the "gold-standard" treatment for this population however, some patients continue to experience symptoms of PTSD following treatment. Examining neural changes associated with successful treatment may suggest adjunctive or additional steps to enhance recovery in non-responders or partly responsive patients.

The investigators will assess brain activation in response to an emotion-related task in 40 adolescents with PTSD before and after a 12 week TF-CBT treatment, conducted at Stanford University. The fidelity of TF-CBT treatment will be assured through ongoing consultation between clinicians and treatment co-creator Judith Cohen, M.D. Neuroimaging analyses will assess patterns of activation associated with response to TF-CBT. Also, the investigators will scan 30 age-matched healthy controls recruited from the same community, to compare with patients to identify abnormalities in brain structure and function in the PTSD group. Controls will be scanned before and after a 12-week interval as well, to allow analyses of test/retest reliability of fMRI measures in this age group.

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Biomarkers of Clinical Response to Cognitive Treatment of PTSD in Youth
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Psychotherapy

Trauma-focused Cognitive Behavioral Therapy

Behavioral: Trauma-focused cognitive behavioral therapy
the 'gold-standard' behavioral treatment for children/adolescents with posttraumatic stress disorder
Other Names:
  • TF-CBT
  • Outcome Measures

    Primary Outcome Measures

    1. functional magnetic resonance imaging (brain activation) [change in brain activation after 4 months of treatment (baseline and 4 months)]

      We will use functional magnetic resonance imaging to measure changes in brain activation after 4 months of psychotherapy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    9 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ages 12-17, history of physical or sexual abuse, witnessing violence, or bullying; and English speaking
    Exclusion Criteria:
    • receiving other psychotherapy currently, taking medications for a psychiatric disorder currently, history of head injury with loss of consciousness longer than 5 minutes; major medical condition such as epilepsy, diabetes, heart disease, or loss of hearing or vision, developmental disorder such as fragile X, autism, or Down's Syndrome, MRI contraindications including metal in the body from an injury or surgery, non-removeable piercings, or braces, Intelligence Quotient (IQ) < 70; schizophrenia, bipolar disorder, current substance abuse.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University Palo Alto California United States 94305

    Sponsors and Collaborators

    • Stanford University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Amy S Garrett, Ph.D., Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Amy Sue Garrett, Principle Investigator, Stanford University
    ClinicalTrials.gov Identifier:
    NCT01806701
    Other Study ID Numbers:
    • MH097769
    • K01MH097769
    First Posted:
    Mar 7, 2013
    Last Update Posted:
    Oct 13, 2016
    Last Verified:
    Oct 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Amy Sue Garrett, Principle Investigator, Stanford University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 13, 2016